These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 2664296

  • 41. Preparation and characterization of platinum(II) and (IV) complexes of 1,3-diaminepropane and 1,4-diaminebutane: circumvention of cisplatin resistance and DNA interstrand cross-link formation in CH1cisR ovarian tumor cells.
    Alvarez-Valdés A, Pérez JM, López-Solera I, Lannegrand R, Continente JM, Amo-Ochoa P, Camazón MJ, Solans X, Font-Bardía M, Navarro-Ranninger C.
    J Med Chem; 2002 Apr 25; 45(9):1835-44. PubMed ID: 11960495
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. The comparative pharmacokinetics of carboplatin and cisplatin in mice and rats.
    Siddik ZH, Newell DR, Boxall FE, Harrap KR.
    Biochem Pharmacol; 1987 Jun 15; 36(12):1925-32. PubMed ID: 3297068
    [Abstract] [Full Text] [Related]

  • 44. Stimulation of the renal endoplasmic reticulum calcium pump: a possible biomarker for platinate toxicity.
    De Witt LM, Jones TW, Moore L.
    Toxicol Appl Pharmacol; 1988 Feb 15; 92(2):157-69. PubMed ID: 2963406
    [Abstract] [Full Text] [Related]

  • 45. Preclinical toxicology and tissue platinum distribution of novel oral antitumour platinum complexes: ammine/amine platinum(IV) dicarboxylates.
    McKeage MJ, Morgan SE, Boxall FE, Murrer BA, Hard GC, Harrap KR.
    Cancer Chemother Pharmacol; 1994 Feb 15; 33(6):497-503. PubMed ID: 8137461
    [Abstract] [Full Text] [Related]

  • 46. Preclinical studies on toxicity, antitumour activity and pharmacokinetics of cisplatin and three recently developed derivatives.
    Lelieveld P, Van der Vijgh WJ, Veldhuizen RW, Van Velzen D, Van Putten LM, Atassi G, Danguy A.
    Eur J Cancer Clin Oncol; 1984 Aug 15; 20(8):1087-104. PubMed ID: 6381064
    [Abstract] [Full Text] [Related]

  • 47. [Acute and subacute toxicity of antineoplastic Pt(II) and Pt(IV) coordination compounds in laboratory rodents].
    Härtl A, Güttner J, Horn U, Jelinek F, Stöckel U, Schröer HP, Hoffmann H.
    Arch Geschwulstforsch; 1989 Aug 15; 59(4):239-44. PubMed ID: 2640563
    [Abstract] [Full Text] [Related]

  • 48. The influence of platinum drugs on the radiation response of rat kidneys.
    van Rongen E, Kuijpers WC, Baten-Wittwer A.
    Radiother Oncol; 1994 May 15; 31(2):138-50. PubMed ID: 8066193
    [Abstract] [Full Text] [Related]

  • 49. In vivo and in vitro effectivity of some platinum complexes.
    Balázová E, Hrubisko M, Ujházy V.
    Neoplasma; 1984 May 15; 31(6):641-7. PubMed ID: 6395026
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Tissue injury and proliferative response induced in rat kidney by cis-diamminedichloroplatinum (II).
    Laurent G, Yernaux V, Nonclercq D, Toubeau G, Maldague P, Tulkens PM, Heuson-Stiennon JA.
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1988 May 15; 55(3):129-45. PubMed ID: 2899921
    [Abstract] [Full Text] [Related]

  • 54. Relationship between age and nephrotoxicity following single low-dose cisplatin (CDDP) injection in rats.
    Namikawa K, Kinsoku A, Minami T, Okazaki Y, Kadota E, Teramura K, Hashimoto S.
    Biol Pharm Bull; 1995 Jul 15; 18(7):957-62. PubMed ID: 7581250
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. In vivo distribution studies of radioactively labelled platinum complexes; cis-dichlorodiammine platinum(II), cis-trans-dichlorodihydroxy-bis-(isopropylamine) platinum(IV), cis-dichloro-bis-cyclopropylamine platinum(II), and cis-diammine 1,1-cyclobutanedicarboxylate platinum(II) in patients with malignant disease, using a gamma camera.
    Owens SE, Thatcher N, Sharma H, Adam N, Harrison R, Smith A, Zaki A, Baer JC, McAuliffe CA, Crowther D.
    Cancer Chemother Pharmacol; 1985 Jul 15; 14(3):253-7. PubMed ID: 3888431
    [Abstract] [Full Text] [Related]

  • 57. Circadian time dependence of murine tolerance for carboplatin.
    Boughattas NA, Lévi F, Hecquet B, Lemaigre G, Roulon A, Fournier C, Reinberg A.
    Toxicol Appl Pharmacol; 1988 Nov 15; 96(2):233-47. PubMed ID: 3057682
    [Abstract] [Full Text] [Related]

  • 58. Dissimilar alterations of sodium-coupled uptake by platinum-coordination complexes in renal proximal tubular cells in primary culture.
    Courjault-Gautier F, Hoet D, Leroy D, Toutain HJ.
    J Pharmacol Exp Ther; 1994 Sep 15; 270(3):1097-104. PubMed ID: 7932157
    [Abstract] [Full Text] [Related]

  • 59. Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA.
    Knox RJ, Friedlos F, Lydall DA, Roberts JJ.
    Cancer Res; 1986 Apr 15; 46(4 Pt 2):1972-9. PubMed ID: 3512077
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.